In 2018, the Society for Immunotherapy of Cancer (SITC) Board of Directors prioritized global access to cancer immunotherapy as a strategic goal for the society. To facilitate this goal, SITC formed the Global Access and Impact Committee. This committee, comprising an array of international stakeholders, seeks to develop strategies that overcome the challenges of science, education, policy and infrastructure within Low- and Middle-Income Countries (LMICs) to promote immunotherapy utilization and access across the world.
Dec. 9–10, 2020 • Virtual Program
Learn More • View On-demand Presentations
SITC and the Global Access and Impact Committee are pleased to convene stakeholders from around the world for the workshop, Global Access to Cancer Immunotherapy: Closing the Gaps. This closed, invite-only virtual workshop seeks to bring together immunotherapy experts from high-income countries with experts on cancer delivery and research from low- and middle-income countries to define optimal approaches to the above challenges. This workshop will focus on the scientific and implementation barriers above, rather than health economics and sustainable funding, with the belief that addressing the former will create more momentum to solve for the latter.
Click here to learn more about this workshop and view the program schedule to access on-demand presentations.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com